-+ 0.00%
-+ 0.00%
-+ 0.00%

*Gilead: To Acquire Investigational Oral IL-23R Inhibitor HCXT-2001, Strengthening Inflammation Pipeline in IBD

Dow Jones·10/22/2026 20:13:00

Please log in to view news